Ampersand Capital Partners

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with over $3 billion in assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, Amsterdam, Netherlands, and London, UK, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. The firm has helped build numerous market-leading companies across each of its core healthcare sectors.

Ampersand's investment strategy focuses on partnering with exceptional founders and management teams to enable future innovations across the healthcare ecosystem. The firm has been recognized for its consistent performance, ranking #1 globally for growth capital private equity performance for three consecutive years by HEC Paris–Dow Jones. Additionally, Ampersand has been named a Top Private Equity Firm by GrowthCap and a Top Performing Private Equity Fund Manager in the Americas by Preqin for multiple years.

The firm's portfolio includes companies such as Specac Limited, a leader in spectroscopy accessories and sample preparation solutions, and Avid Bioservices, a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries. Ampersand's collaborative approach with portfolio companies emphasizes strategic resources, operating experience, and support to scale effectively while preserving founder vision and culture.